Table 3.
Phase 3 trials of thalidomide maintenance therapy after autologous SCT for myeloma
View large
Phase 3 trials of thalidomide maintenance therapy after autologous SCT for myeloma

T indicates thalidomide; Pam, pamidronate; Pred, prednisone; and NS, not significant.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal